Literature DB >> 9297655

Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.

J P Realini1, C E Encarnacion, K N Chintapalli, C R Rees.   

Abstract

BACKGROUND: Previous epidemiologic studies of venous thromboembolism and oral contraceptive use are susceptible to bias in the detection of venous thromboembolic events. This case-control study uses a unique design to minimize the influence of detection bias.
METHODS: Nonpredisposed women younger than the age of 40 years who underwent pulmonary angiography, lower extremity venography, or lower extremity duplex Doppler sonography at a large urban hospital were classified into a case group or control group based on results of their diagnostic studies. Medical records were reviewed for a history of current oral contraceptive use.
RESULTS: Fifty-seven women met the study criteria during the 11-year study period. Seven of 9 women in the case group and 17 of 48 women in the control group were currently using oral contraceptives (odds ratio 6.38; 95 percent confidence limits 1.19, 34.2).
CONCLUSIONS: The association previously noted between venous thromboembolism and oral contraceptive use is not due to bias in the detection of venous thromboembolic events.

Entities:  

Keywords:  Americas; Bias; Biology; Case Control Studies; Contraception; Contraceptive Methods--side effects; Developed Countries; Diseases; Embolism; Error Sources; Evaluation; Family Planning; Measurement; North America; Northern America; Oral Contraceptives, Combined--side effects; Oral Contraceptives--side effects; Research Methodology; Research Report; Risk Assessment; Risk Factors; Studies; Texas; Thromboembolism; United States; Vascular Diseases

Mesh:

Substances:

Year:  1997        PMID: 9297655

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  2 in total

Review 1.  Cardiovascular events associated with different combined oral contraceptives: a review of current data.

Authors:  P Hannaford
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Norethisterone enanthate-induced cerebral venous sinus thrombosis (CVST).

Authors:  Mandreker Bahall; Manisha Santlal
Journal:  BMJ Case Rep       Date:  2017-11-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.